Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04533763 · ClinicalTrials.gov registry record · NA

Living WELL: A Web-Based Program for Ovarian Cancer Survivors

A NA study of Ovarian Cancer, sponsored by Susan Lutgendorf.

Active
Registry status
NA
Development phase
326
Enrollment target
4
Study locations

NCT04533763: Active NA study of Ovarian Cancer, sponsored by Susan Lutgendorf.

NCT04533763 is a NA study of Ovarian Cancer that is active but no longer recruiting, run by Susan Lutgendorf. The registered enrollment target is 326 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (55% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04533763, a NA study of Ovarian Cancer, is active but no longer recruiting, sponsored by Susan Lutgendorf.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
326 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to determine the efficacy of a group-based and web-delivered psychosocial intervention for ovarian cancer survivors (Mindful Living \[ML\]) compared to a health promotion condition (Healthy Lifestyles \[HL\]) in increasing health related quality of life (HRQOL) and decreasing perceived stress (primary aim), and decreasing anxiety, depressive mood, and fatigue (secondary aims) across a 12-month period.

Primary Outcome

HRQOL will be measured by the Functional Assessment of Cancer Therapy (FACT-O) survey, a health survey designed to assess multiple dimensions of HRQOL. Higher scores indicate better HRQOL.

Conditions Studied

Interventions

  • BEHAVIORAL Technology-based Mindful Living program
  • BEHAVIORAL Technology-based Healthy Lifestyles program

Study Locations (4)

Florida

  • University of Miami - Miami

Iowa

  • University of Iowa Hospitals & Clinics - Iowa City

Nebraska

  • University of Nebraska Medical Center - Omaha

Washington

  • University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 326 participants
Start Date 2020-09-30
Est. Completion 2026-01-31
Phase NA
Susan Lutgendorf

2 total trials

What the registry record for NCT04533763 still lists

NCT04533763 is an interventional study that assigns participants to a tested intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (55% lower).

The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Technology-based Mindful Living program is the first listed.

NCT04533763 reports a single indexed study location in Florida, Iowa, Nebraska.

Frequently Asked Questions

What is clinical trial NCT04533763 about?

NCT04533763 is a clinical study titled "Living WELL: A Web-Based Program for Ovarian Cancer Survivors". The purpose of this study is to determine the efficacy of a group-based and web-delivered psychosocial intervention for ovarian cancer survivors (Mindful Living \[ML\]) compared to a health promotion condition (Healthy Lifestyles \[HL\]) in increasing health related quality of life (HRQOL) and decre...

What is the current status of trial NCT04533763?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 326 participants. The study started on 2020-09-30. Estimated completion is 2026-01-31.

What conditions does trial NCT04533763 study?

This clinical trial studies the following conditions: Ovarian Cancer.

What interventions are being tested in trial NCT04533763?

The interventions under investigation include: Technology-based Mindful Living program (BEHAVIORAL), Technology-based Healthy Lifestyles program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04533763?

This trial is sponsored by Susan Lutgendorf, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04533763 being conducted?

This trial has 4 study locations across Florida, Iowa, Nebraska, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ovarian Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04533763's enrollment target sits among peer trials

326 65th of 322 higher than 258 of 322 other Ovarian Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06410144 · 326 participants · NA

    Chronic Kidney Disease-Education (CKD-EDU)

  • NCT06586619 · 326 participants · NA

    A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV

  • NCT07040566 · 326 participants · Phase 2

    A Trial of Varenicline for E-cigarette Cessation

  • NCT07165860 · 326 participants · NA

    Clinical Trial to Reduce Perinatal Intimate Partner Violence

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04533763, the US trial registry maintained by the National Library of Medicine. NCT04533763 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.